References
- Chan JK, Jaffe ES, Ralfkiaer E. Extranodal NK/T-cell lymphoma, nasal type. Tumours of haematopoietic and lymphoid tissues. World Health Organization Classification of Tumours, ES Jaffe, NL Harris, H Stein, JW Vardiman. IARC Press, Lyon 2001; 204–207
- Chan JK, Wong KF, Jaffe ES, Ralfkiaer E. Aggressive NK-cell leukaemia. Tumours of haematopoietic and lymphoid tissues. World Health Organization Classification of Tumours, ES Jaffe, NL Harris, H Stein, JW Vardiman. IARC Press, Lyon 2001; 198–200
- Au W, Ma SY, Chim CS, Choy C, Loong F, Lie AKW, et al. Clinicopathologic features and treatment outcome of mature T cell and natural killer-cell lymphomas diagnosed according to World Health Organization classification scheme: A single centre experience of 10 years. Ann Oncol 2005; 16: 206–14
- Nava VE, Jaffe ES. The pathology of NK-cell lymphomas and leukemias. Adv Anat Pathol 2005; 12: 27–34
- Ng SB, Lai KW, Murugaya S, Lee KM, Loong SL, Fook-Chong S, et al. Nasal-type extranodal natural killer/T cell lymphomas: A clinicopathologic and genotypic study of 42 cases in Singapore. Mod Pathol 2004; 17: 1097–107
- Vose, JM. The International PTCL Project International Peripheral T-cell Lymphoma (PTCL) Clinical and Pathologic Review Project: Poor outcome by prognostic indices and lack of efficacy with anthracyclines. Blood (ASH Annual Meeting Abstracts). 2005;106:811.
- Lee J, Suh C, Park YH, Ko YH, Bong SM, Lee JH, et al. Extranodal natural killer T-cell lymphoma, nasal type: A prospective model from retrospective multicentre study. JCO 2006; 24: 612–8
- Lim ST, Hee SW, Quek R, Lim LC, Yap SP, Loong EL, et al. Comparative analysis of extra-nodal NK/T-cell lymphoma and peripheral T-cell lymphoma: Significant differences in clinical characteristics and prognosis. Eur J Haematol 2008; 80: 55–60
- Kwong YL. Natural killer-cell malignancies: Diagnosis and treatment. Leukemia 2005; 19: 2186–94
- Lee KW, Yun T, Kim DW, Im SA, Kim TY, Yoon SS, et al. First line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy±radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma. Leuk Lymphoma 2006; 47: 1274–82
- Kandylis K, Vassilomanolakis M, Tsoussis S, Efremidis AP. Ifosfamide cardiotoxicity in humans. Cancer Chemother Pharmacol 1989; 24: 395–6
- Roberts WC, Glancy DL, DeVita VT. Heart in malignant lymphoma (Hodgkin's disease, lymphosarcoma, reticulum cell sarcoma and mycosis fungoides): A study of 196 autopsy cases. Am J Cardiol 1968; 22: 85–107
- Lam KY, Dickens P, Chan ACL. Tumors of the heart: A 20-year experience with a review of 12 485 consecutive autopsies. Arch Pathol Lab Med 1993; 117: 1027–31
- Dorsay TA, Ho VB, Rovira MJ, Armstrong MA, Brisette MD. Primary cardiac lymphoma: CT and MR findings. J Comput Assist Tomogr 1993; 17: 978–81
- Burton C, Ell P, Linch D. The role of PET imaging in lymphoma. Br J Haematol 2004; 126: 772–84